Literature DB >> 11262867

Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects.

C Mulrow, V Lawrence, B Jacobs, C Dennehy, J Sapp, G Ramirez, C Aguilar, K Montgomery, L Morbidoni, J M Arterburn, E Chiquette, M Harris, D Mullins, A Vickers, K Flora.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11262867      PMCID： PMC4781343     

Source DB:  PubMed          Journal:  Evid Rep Technol Assess (Summ)        ISSN： 1530-440X


× No keyword cloud information.
  6 in total

Review 1.  Herbal supplements.

Authors:  Timothy O Lipman
Journal:  Curr Gastroenterol Rep       Date:  2005-08

2.  A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.

Authors:  Samer S El-Kamary; Michelle D Shardell; Mohamed Abdel-Hamid; Soheir Ismail; Mohamed El-Ateek; Mohamed Metwally; Nabiel Mikhail; Mohamed Hashem; Amr Mousa; Amr Aboul-Fotouh; Mohamed El-Kassas; Gamal Esmat; G Thomas Strickland
Journal:  Phytomedicine       Date:  2009-03-19       Impact factor: 5.340

Review 3.  Systematic reviews of complementary therapies - an annotated bibliography. Part 2: herbal medicine.

Authors:  K Linde; G ter Riet; M Hondras; A Vickers; R Saller; D Melchart
Journal:  BMC Complement Altern Med       Date:  2001-07-20       Impact factor: 3.659

4.  Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.

Authors:  Ommoleila Molavi; Farzaneh Narimani; Farshid Asiaee; Simin Sharifi; Vahideh Tarhriz; Ali Shayanfar; Mohammadsaied Hejazi; Raymond Lai
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 5.  Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.

Authors:  A Rambaldi; B P Jacobs; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 6.  Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials.

Authors:  Zongguo Yang; Liping Zhuang; Yunfei Lu; Qingnian Xu; Xiaorong Chen
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.